Celebrity Inventors
Actor Marlon Brando has four patents, all named "Drumhead tensioning device and method."
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8153587 | Orally administering parathyroid hormone and calcitonin A method for orally administering a parathyroid hormone, PTH, comprising orally co-administering to a patient in need of PTH an effective amount of a PTH and an effective amount of calcitonin. The method according to the invention allows for the oral administration ... | 04/10/2012 |
| 8124795 | Process for modifying drug crystal formation A process for modifying the crystal habit of acicular drug substances, crystals obtained by such a process, and particular crystal forms or modifications of mycophenolic acid or mycophenolate sodium are provided, as well as pharmaceutical compositions comprising the... | 02/28/2012 |
| 8008511 | Process for modifying drug crystal formation A process for modifying the crystal habit of acicular drug substances, crystals obtained by such a process, and particular crystal forms or modifications of mycophenolic acid or mycophenolate sodium are provided, as well as pharmaceutical compositions comprising the... | 08/30/2011 |
| 7749954 | Use of calcitonin in osteoarthritis The present invention relates to a novel use of calcitonin in osteoarthritis, and to methods of treating and/or preventing osteoarthritis in mammals, particularly humans. ... | 07/06/2010 |
| 7612210 | Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols A process for the enantioselective synthesis of an (S)- or (R)-1-[2-dimethylamino)-1-(methoxyphenyl)ethyl]cyclohexanol and analogues or salt thereof are described. The method involves the steps of (a) reacting an (S) or (R) 4-benzyloxazolidinone with a mixed anhydri... | 11/03/2009 |
| 7601744 | Benzothiadiazolylphenylalkylamine derivatives and methods of their use The present invention is directed to benzothiadiazolylphenylalkylamine derivatives of formula I: or a pharmaceutically acceptable salt thereof, compositions containing these derivatives, and methods of their use for the pre... | 10/13/2009 |
| 7595340 | Serotonin and norepinephrine reuptake inhibitor and uses thereof Selective dual serotonin and norepinephrine reuptake inhibitors are provided. These compounds have a lower side-effect profile and are useful in compositions and products for use in treatment of a variety of conditions including depression, fibromyalgia, anxiety, pa... | 09/29/2009 |
| 7589108 | 1-Heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor. ... | 09/15/2009 |
| 7585876 | Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor. ... | 09/08/2009 |
| 7563796 | Diphenylimidazopyrimidines as inhibitors of β-secretase The present invention provides an amino-imidazolone compound of formula I Also provided are compositions and methods for the use thereof to inhibit β-secretase (BACE) and treat β-amyloid deposits and neurofibrillary tangles... | 07/21/2009 |
| 7238723 | Indole derivatives The present invention provides eletriptan hydrobromide monohydrate of the formula (I): together with processes for preparing, uses of, and compositions containing, said monohydrate. ... | 07/03/2007 |
| 7235363 | Method for the screening of αδ-1 subunit binding ligands A method for the screening of ligands which bind to soluble α2δ-1 subtype polypeptides. ... | 06/26/2007 |
| 7214824 | Substituted -sulfonylaminobenzyl-2-phenoxyacetamide compounds as VR1 receptor agonists This invention provides a compound of the formula (I): wherein R1 represents a (C1–C6)alkyl group; R2 represents a hydrogen atom, a halogen atom, a hydroxy group, a (... | 05/08/2007 |
| 7214676 | Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors The invention provides compounds which are PDE7 inhibitors, having the following formula (I), (II) and (III) in which X1, X2, X3, X4, X, Y, Z, A and Z1 are a... | 05/08/2007 |
| 7179934 | Amino acids with affinity for the α2δ-protein Certain β-amino acids that bind to the alpha-2-delta (α2δ) subunit of a calcium channel are disclosed. These compounds and their pharmaceutically acceptable salts are useful in the treatment of a variety of psychiatric, pain and other disorders. Also disclosed ar... | 02/20/2007 |
| 7164030 | Process The present invention provides an improved process for the preparation of α-polymorphic eletriptan hydrobromide. ... | 01/16/2007 |
| 7148234 | Use of EP4 receptor ligands in the treatment of IL-6 involved diseases Methods of treating IL-6 involved diseases with EP4 receptor ligands, including EP4 receptor antagonists. Assays to determine the effect of test compounds on PGE2-induced whole blood cells activation. ... | 12/12/2006 |
| 7141580 | Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents This invention provides a compound of the formula (I): or the pharmaceutically acceptable salts thereof, wherein Y1, Y2, Y3 and Y4 are independently selected from N, CH... | 11/28/2006 |
| 7138542 | Method of treating tinnitus The invention relates to a method of treating tinnitus by administering an alpha2delta ligand such as, for example, a compound of Formula and pharmaceutically acceptable salts thereof, wherein R1 is hy... | 11/21/2006 |
| 7132549 | Process The present invention provides an improved process for the preparation of a polymorph of eletriptan hemisulphate. ... | 11/07/2006 |
| 7053122 | Therapeutic use of aryl amino acid derivatives The compounds of formula (I) are useful in the treatment of faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, neuropathic pain, neuropathological disorder... | 05/30/2006 |
| 7026505 | Method of treating tinnitus The invention relates to a method of treating tinnitus by administering an alpha2delta ligand such as, for example, a compound of Formula and pharmaceutically acceptable salts thereof, wherein R1 is hydrogen ... | 04/11/2006 |
| 7022678 | Pregabalin lactose conjugates In accordance with the present invention, there is provided pregabalin lactose conjugate compounds. Also provided as part of the present invention is a novel method of central nervous system disorders or diseases including seizure disorders, pain, depression,... | 04/04/2006 |
| 7018818 | Intermediates in the preparation of therapeutic fused bicyclic amino acids The invention presents compounds of formula (I), where R represents H or a suitable carboxylic acid protecting group, which are intermediates in the preparation of therapeutic fused bicyclic amino acids. ... | 03/28/2006 |
| 7001917 | Pyrazole compounds as anti-inflammatory and analgesic agents This invention provides a compound of the formula (I): wherein: R1 represents a hydrogen atom, an alkyl group, etc.; R2 represents a hydrogen atom, a halogen atom, etc.; R3 | 02/21/2006 |
| 6964962 | Combinations of reboxetine and neuroleptic agents A composition comprising: (a) a pharmaceutically effective amount of reboxetine; and selected from the group consisting of clozapine, olanzapine, risperidone and mixtures thereof (b) a pharmaceutically effective amount of one or more neurol... | 11/15/2005 |
| 6956050 | Imidazole compounds as anti-inflammatory and analgesic agents This invention provides a compound of the formula (I): wherein: R1 represents a hydrogen atom, an alkyl group, etc.; R2 represents a hydrogen atom, a halogen atom, etc.; R3 | 10/18/2005 |
| 6942876 | Analgesic compositions comprising anti-epileptic compounds and methods of using same The present invention is directed to novel combinations of anti-epileptic compounds that demonstrate pain alleviating properties, with compounds selected from the group consisting of analgesics, NMDA receptor antagonists, and NSAIDs and pharmaceutical compositions c... | 09/13/2005 |
| 6919377 | Cyclohexylamine derivative as subtype selective NMDA receptor antagonists Described are compounds of Formula I and Formula II and their pharmaceutically acceptable salts. The compounds of Formulas I and II are antagonists of NMDA receptor channel complexes useful for treating cerebral vascular disorders such as, for example, cerebral isch... | 07/19/2005 |
| 6914145 | Acylation process The present invention is concerned with the acylation of indoles, specifically the preparation of 3-acylated indoles which may be further treated to provide indoles having an alternative substituent at the 3-position. ... | 07/05/2005 |
| 6911555 | Cyclic nitromethyl acetic acid derivatives The invention provides salts of formula (I) wherein X is a basic counterion selected from a group I or group II metal and a primary, secondary or tertiary amine; n is 0, 1 or 2; and R1 | 06/28/2005 |
| 6887902 | Anti-inflammatory method using gamma-aminobutyric acid (GABA) analogs GABA analogs such as gabapentin and pregabalin are useful to prevent and treat inflammatory diseases. ... | 05/03/2005 |
| 6869960 | N-substituted spiropiperidine compounds as ligands for ORL-1 receptor A compound of the formula: or a pharmaceutically acceptable salt, ester or ether thereof, wherein R1 through R12 are independently hydrogen or the like; X1 and X2 are indepen... | 03/22/2005 |
| 6861425 | Benzimidazole compounds as ORL1-receptor agonists A compound of the formula: or a pharmaceutically acceptable salt thereof, wherein R1 is unsubstituted, mono-, di- or tri-substituted (C3-C11)cycloalkyl or (C3-C11)... | 03/01/2005 |
| 6846953 | Aromatic amides Aromatic and heteroaromatic amides of the formula where R1, R2 and R3 can be alkyl, X is alkylene, and R4 is an unsubstituted or substituted aromatic or heteroaromatic group ... | 01/25/2005 |
| 6835751 | Bicyclic amino acids as pharmaceutical agents The compounds of the instant invention are bicyclic amino acids useful in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, arthritis, neuropathological disorders, and sleep d... | 12/28/2004 |
| 6828341 | Cyclohexylamine derivatives as subtype selective N-Methyl-D-Aspartate antagonists Described are cyclohexylamine derivatives of Formula I and pharmaceutically acceptable salts thereof, wherein R1, g, *, R, V, B, E, Y, G, H, X1, and d are as defined in the description. The compou... | 12/07/2004 |
| 6794402 | Bicyclic cyclohexylamines and their use as NMDA receptor antagonists Described are bicycle-substituted cyclohexylamines of Formula I and their pharmaceutically acceptable salts thereof: The compounds are antagonists of NMDA receptor channel complexes useful for treating cerebral vascular ... | 09/21/2004 |
| 6783952 | Secreted soluble α2δ-2, α2δ-3 or α2δ-4 calcium channel subunit polypeptides and screening assays using same Soluble α2δ sub-type polypeptides. Methods for cloning, expression and purification of freely soluble α2δ subtype polypeptides. A method for the screening of ligands which bind to soluble α2δ subtype polypeptides.... | 08/31/2004 |
| 6784208 | Method for preventing and treating visceral pain and gastrointestinal disorders The compounds of formula I-IV: wherein n is an integer of from 1 to 4, or pharmaceutically acceptable salts thereof are useful to prevent and treat visceral pain and gastrointestinal disorders. ... | 08/31/2004 |
